Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

Avimers hold their own

Antibody surrogates based on a class of human receptor domains bind protein targets with high affinity.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Avimer construction.

Bob Crimi

References

  1. Silverman, J. et al. Nat. Biotechnol. 23, 1556–1561 (2005).

    Article  CAS  Google Scholar 

  2. Baker, M. Nat. Biotechnol. 23, 1065–1072 (2005).

    Article  CAS  Google Scholar 

  3. Hoogenboom, H.R. Nat. Biotechnol. 23, 1105–11016. (2005)

    Article  CAS  Google Scholar 

  4. Binz, H.K., Amstutz, P. & Pluckthun, A. Nat. Biotechnol. 23, 1257–1268 (2005).

    Article  CAS  Google Scholar 

  5. Mabry, R. et al. Infect. Immun. (in the press).

  6. Hamilton, S.R. et al. Science. 301, 1244–1246 (2003).

    Article  CAS  Google Scholar 

  7. Harvey, B.R. et al. Proc. Natl. Acad. Sci. USA 101, 9193–9198 (2004).

    Article  CAS  Google Scholar 

  8. Binz, H.K. et al. Nat. Biotechnol. 22, 575–582 (2004).

    Article  CAS  Google Scholar 

  9. North, C.L. & Blacklow, S.C. Biochemistry 38, 3926–3935 (1999).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Jeong, K., Mabry, R. & Georgiou, G. Avimers hold their own. Nat Biotechnol 23, 1493–1494 (2005). https://doi.org/10.1038/nbt1205-1493

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/nbt1205-1493

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing